Literature DB >> 19428376

GPX1 Pro(198)Leu polymorphism, erythrocyte GPX activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer.

Rikke Dalgaard Hansen1, Britta Naimi Krath, Kirsten Frederiksen, Anne Tjønneland, Kim Overvad, Nina Roswall, Steffen Loft, Lars Ove Dragsted, Ulla Vogel, Ole Raaschou-Nielsen.   

Abstract

GPX1 encoding the enzyme glutathione peroxidase 1 (GPX1) and hOGG1 encoding the 8-oxoguanine glycosylase 1 (OGG1) may counteract oxidative stress and resulting DNA damage associated with lifestyle-related exposures. We examined whether the polymorphisms GPX1 Pro(198)Leu and OGG1 Ser(326)Cys or low erythrocyte GPX enzyme activity in pre-diagnostic blood samples are associated with colorectal cancer risk, and assessed possible interactions between the polymorphisms or enzyme activity and various lifestyle factors in relation to colorectal cancer risk. Additionally, we studied whether the GPX1 Pro(198)Leu polymorphism and several lifestyle factors predict GPX activity in erythrocytes. The present study was nested within the prospective "Diet, Cancer and Health" study of 57,053 Danes including 375 colorectal cancer cases and a comparison group of 779 individuals matched on gender. Biomaterial was sampled and information on lifestyle factors was obtained from questionnaires filled in at enrolment in 1993-1997. GPX1 Pro(198)Leu, hOGG1 Ser(326)Cys and erythrocyte GPX enzyme activity were not associated with risk of colorectal cancer. We observed a higher risk associated with alcohol consumption and smoking among homozygous GPX1(198)Leu carriers, with incidence rate ratios for colorectal cancer of 1.45 (95% CI: 1.17-1.81, P=0.02) per 10g alcohol intake per day and 2.56 (95% CI: 0.99-6.61, P=0.02) among ever smokers compared with never smokers at enrolment. Erythrocyte GPX activity was influenced by the GPX1 Pro(198)Leu genotype, gender, smoking intensity, and intake of fruits and vegetables. Our results indicate that lifestyle-related oxidative stress may be a risk factor for colorectal cancer among subjects with a lowered defence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428376     DOI: 10.1016/j.mrfmmm.2009.01.009

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  37 in total

1.  Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer.

Authors:  Ulrike Haug; Elizabeth M Poole; Liren Xiao; Karen Curtin; David Duggan; Li Hsu; Karen W Makar; Ulrike Peters; Richard J Kulmacz; John D Potter; Lisel Koepl; Bette J Caan; Martha L Slattery; Cornelia M Ulrich
Journal:  Genes Chromosomes Cancer       Date:  2012-02-27       Impact factor: 5.006

2.  Genetic association between hOGG1 C8069G polymorphism and colorectal cancer risk.

Authors:  Xiaoge Sun; Hao Yang; Yu Lin; Jianguo Zhao; Yinna Bao; Xiulan Liu; Zhen Qi; Shaojun Wang; Congxiu Huang; Zhilong Yu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  Loss of heterozygosity at the glutathione peroxidase 1 locus is not an early event in colon carcinogenesis.

Authors:  Marci Goldberg; David S Alberts; Julie A Buckmeier; Anil R Prasad; Robert S Krouse; Alan M Diamond
Journal:  Genes Cancer       Date:  2011-09

Review 4.  Selenoproteins in colon cancer.

Authors:  Kristin M Peters; Bradley A Carlson; Vadim N Gladyshev; Petra A Tsuji
Journal:  Free Radic Biol Med       Date:  2018-05-22       Impact factor: 7.376

5.  Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis.

Authors:  Yumie Takata; Alan R Kristal; Irena B King; Xiaoling Song; Alan M Diamond; Charles B Foster; Carolyn M Hutter; Li Hsu; David J Duggan; Robert D Langer; Helen Petrovitch; James M Shikany; Thomas L Vaughan; Johanna W Lampe; Ross L Prentice; Ulrike Peters
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-15       Impact factor: 4.254

Review 6.  A systematic review and meta-analysis of the association between OGG1 Ser326Cys polymorphism and cancers.

Authors:  Ping-Ting Zhou; Bo Li; Jun Ji; Meng-Meng Wang; Chun-Fang Gao
Journal:  Med Oncol       Date:  2015-01-15       Impact factor: 3.064

7.  Status of antioxidant enzyme: glutathione peroxidase and total polyphenol level in plasma of Tunisian patients suffering from colorectal and gastric cancer: interaction with clinical outcome.

Authors:  Olfa Baroudi; Sonia Ben Younes; Amel Mézlini; Yves Jean Bignon; Imen Medimeg; Nancy Uhrhammer; Amel Ben Ammar E L Gaiied; Soufia Chabchoub Ellouz
Journal:  Med Oncol       Date:  2013-09-27       Impact factor: 3.064

8.  Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population.

Authors:  Canan Kucukgergin; Oner Sanli; Akın S Amasyalı; Tzevat Tefik; Sule Seckin
Journal:  Med Oncol       Date:  2011-09-09       Impact factor: 3.064

Review 9.  Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities.

Authors:  Edith Lubos; Joseph Loscalzo; Diane E Handy
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

10.  GPX1 gene Pro200Leu polymorphism, erythrocyte GPX activity, and cancer risk.

Authors:  Zhiqiang Hong; Changwei Tian; Xingliang Zhang
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.